Total Glucosides of Danggui Buxue Tang Attenuate BLM-Induced Pulmonary Fibrosis via Regulating Oxidative Stress by Inhibiting NOX4

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Zhao, Ping ^a   Zhou, Wen Cheng ^b   Li, De Lin ^a   Mo, Xiao Ting ^b   Xu, Liang ^a   Li, Liu Cheng ^b   Cui, Wen Hui ^b   Gao, Jian ^b  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CARBOHYDRATES; ENZYME INHIBITION; ENZYMES; HYDROXYPROLINE; MOLECULAR OXYGEN; OXYGEN; PLANTS (BOTANY); PROTEINS;

CHRONIC LUNG DISEASE; MOLECULAR MECHANISM; PULMONARY FIBROSIS; REACTIVE OXYGEN SPECIES; SMOOTH MUSCLE ACTINS; SUPEROXIDE DISMUTASE ACTIVITIES; TOTAL ANTIOXIDANT CAPACITY; TRANSFORMING GROWTH FACTORS;

OXIDATIVE STRESS;

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; COLLAGEN TYPE 1; DANGGUI BUXUE TANG; HERBACEOUS AGENT; HYDROXYPROLINE; MALONALDEHYDE; PREDNISONE; PROSTAGLANDIN DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BIOLOGICAL PRODUCT; DANGGUI BUXUE DECOCTION; GLUCOSIDE; NOX4 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; LUNG FIBROSIS; LUNG HOMOGENATE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; ANIMAL; CHEMICALLY INDUCED; HUMAN; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; BIOLOGICAL PRODUCTS; BLEOMYCIN; DRUGS, CHINESE HERBAL; GLUCOSIDES; HUMANS; NADPH OXIDASE; OXIDATIVE STRESS; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 84940398478     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/645814     Document Type: Article

References (24)

1. M. Gharaee-Kermani, B. Hu, S. H. Phan, and M. R. Gyetko, "Recent advances in molecular targets and treatment of Idiopathic Pulmonary Fibrosis: focus on TGF signaling and the myofibroblast," Current Medicinal Chemistry, vol. 16, no. 11, pp. 1400-1417, 2009.
2. L. Nalysnyk, J. Cid-Ruzafa, P. Rotella, and D. Esser, "Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature," European Respiratory Review, vol. 21, no. 126, pp. 355-361, 2012.
3. H. I. Adamali and T. M. Maher, "Current and novel drug therapies for idiopathic pulmonary fibrosis," Drug Design, Development andTherapy, vol. 6, pp. 261-272, 2012.
4. B. M. Hybertson, B. Gao, S. K. Bose, and J. M. McCord, "Oxidative stress in health and disease: the therapeutic potential ofNrf2 activation,"Molecular Aspects ofMedicine, vol. 32,no. 4-6, pp. 234-246, 2011.
5. P. Cheresh, S.-J. Kim, S. Tulasiram, and D. W. Kamp, "Oxidative stress and pulmonary fibrosis," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1832, no. 7, pp. 1028-1040, 2013.
6. S. Piera-Velazquez and S. A. Jimenez, "Role of cellular senescence andNOX4-mediated oxidative stress in systemic sclerosis pathogenesis," Current Rheumatology Reports, vol. 17, article 473, 11 pages, 2014.
7. L. Hecker, R. Vittal, T. Jones et al. , "NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury," Nature Medicine, vol. 15, no. 9, pp. 1077-1081, 2009.
8. L. Hecker, N. J. Logsdon, D. Kurundkar et al. , "Reversal of persistent fibrosis in aging by targetingNox4-Nrf2 redox imbalance," Science Translational Medicine, vol. 6, no. 231, Article ID 231ra47, 2014.
9. P. Wang, Y. Liang, N. Zhou et al. , "Screening and analysis of themultiple absorbed bioactive components andmetabolites of Dangguibuxue decoction by the metabolic fingerprinting technique and liquid chromatography/diode-array detection mass spectrometry," Rapid Communications in Mass Spectrometry, vol. 21, no. 2, pp. 99-106, 2007.
10. L. Fang, C. Cheng, T. Hwanget al. , "Dangguibuxue tang inhibits 2,4-dinitrochlorobenzene: induced atopic dermatitis in mice," Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 672891, 10 pages, 2015.
11. A. G. Gong, N. Li, K. Lau et al. , "Calycosin orchestrates the functions of Danggui Buxue Tang, a Chinese herbal decoction composing of Astragali Radix and Angelica Sinensis Radix: an evaluation by using calycosin-knock out herbal extract," Journal of Ethnopharmacology, vol. 168, pp. 150-157, 2015.
12. J. Gao, Y. Huang, P. Li et al. , "Antifibrosis effects of total glucosides ofDanggui-Buxue-Tang in a ratmodel of bleomycininduced pulmonary fibrosis," Journal of Ethnopharmacology, vol. 136, no. 1, pp. 21-26, 2011.
13. J. Gao, L.-J. Feng, Y. Huang et al. , "Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodelling," Journal of Pharmacy and Pharmacology, vol. 64, no. 6, pp. 811-820, 2012.
14. J. Gao, Q. Xia, Z. G. Huang, D. J. Xu, and J. Li, "Simultaneous assay of astragaloside IV and astragaloside II in total glucosides of Danggui Buxue Decoction by HPLC-ELSD," Chinese Traditional Patent Medicine, vol. 34, pp. 268-272, 2012 (Chinese).
15. Z. G. Huang, J. Gao, P. Li et al. , "Fingerprint of total glucosides of Danggui Buxue Tang by HPLC," Traditional PatentMedicine, vol. 32, pp. 1284-1286, 2010 (Chinese).
16. Z. H. Hoo and M. K. B. Whyte, "Idiopathic pulmonary fibrosis," Thorax, vol. 67, no. 8, pp. 742-746, 2012.
17. N. W. Todd, I. G. Luzina, and S. P. Atamas, "Molecular and cellular mechanisms of pulmonary fibrosis," Fibrogenesis and Tissue Repair, vol. 5, no. 1, article 11, 2012.
18. L. T. Tang, T. Jiang, X. L. Han, and D. L. Chen, "Effect of tranilast on bleomycin induced pulmonary fibrosis in a rat model," African Journal of Pharmacy and Pharmacology, vol. 5, no. 10, pp. 1315-1320, 2011.
19. T. H. Sisson, M. Mendez, K. Choi et al. , "Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis," American Journal of Respiratory and Critical CareMedicine, vol. 181, no. 3, pp. 254-263, 2010.
20. V. L. Kinnula and M. Myllärniemi, "Oxidant-antioxidant imbalance as a potential contributor to the progression of human pulmonary fibrosis," Antioxidants and Redox Signaling, vol. 10, no. 4, pp. 727-738, 2008.
21. Y. Cui, J. Robertson, S. Maharaj et al. , "Oxidative stress contributes to the induction and persistence of TGF-beta1 induced pulmonary fibrosis," International Journal of Biochemistry and Cell Biology, vol. 43, no. 8, pp. 1122-1133, 2011.
22. E. R. Jarman, V. S. Khambata, C. Cope et al. , "An Inhibitor of NADPHoxidase-4 attenuates established pulmonary fibrosis in a rodent disease model," American Journal of Respiratory Cell and Molecular Biology, vol. 50, no. 1, pp. 158-169, 2014.
23. C. R. Kliment and T. D. Oury, "Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis," Free Radical Biology and Medicine, vol. 49, no. 5, pp. 707-717, 2010.
24. O. R. Temneanu, C. Zamfir, F. E. Zugun, E. Cojocaru, and L. Tocan, "Oxidants and antioxidants relevance in rats' pulmonary induced oxidative stress," Journal ofMedicine andLife, vol. 4, no. 3, pp. 244-249, 2011.